We are live on ! Find out more
KRON

Kronos Bio
KRON

Delisted

KRON was delisted on the 20th of June, 2025.

Back to rankings

0 hedge funds and large institutions have $0 invested in Kronos Bio in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 47 closing their positions.

New
Increased
Maintained
Reduced
Closed

31.38% less ownership

Funds ownership: 31.38% → 0% (-31%)

100% less funds holding

Funds holding: 47 → 0 (-47)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less capital invested

Capital invested by funds: $15.8M → $0 (-$15.8M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 47

Holders
–
Holders Change
-47
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
47
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
VVA
Vida Ventures Advisors
Massachusetts
-$2.28M
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.59M
3
PCIG
Partners Capital Investment Group
Massachusetts
-$1.2M
4
AI
Alphabet Inc
California
-$1.19M
5
Millennium Management
Millennium Management
New York
-$1.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
VVA
1
Vida Ventures Advisors
Massachusetts
– -$2.28M -2,765,314 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
– -$1.59M -1,922,809 Closed
PCIG
3
Partners Capital Investment Group
Massachusetts
– -$1.2M -1,448,654 Closed
AI
4
Alphabet Inc
California
– -$1.19M -1,438,232 Closed
Millennium Management
5
Millennium Management
New York
– -$1.18M -1,425,065 Closed
TCM
6
Tang Capital Management
California
– -$1.11M -1,345,413 Closed
WCM
7
Wildcat Capital Management
New York
– -$1.07M -1,297,959 Closed
Acadian Asset Management
8
Acadian Asset Management
Massachusetts
– -$1.01M -1,230,770 Closed
Renaissance Technologies
9
Renaissance Technologies
New York
– -$909K -1,102,326 Closed
SL
10
Siren LLC
Connecticut
– -$695K -842,954 Closed
BlackRock
11
BlackRock
New York
– -$551K -667,399 Closed
PLC
12
Peapod Lane Capital
New York
– -$466K -564,572 Closed
Geode Capital Management
13
Geode Capital Management
Massachusetts
– -$395K -478,208 Closed
Cerity Partners
14
Cerity Partners
New York
– -$339K -410,796 Closed
WP
15
Woodline Partners
California
– -$253K -306,946 Closed
G
16
GenTrust
Florida
– -$244K -295,246 Closed
State Street
17
State Street
Massachusetts
– -$141K -171,225 Closed
Susquehanna International Group
18
Susquehanna International Group
Pennsylvania
– -$128K -155,188 Closed
DAM
19
Deltec Asset Management
New York
– -$124K -150,000 Closed
DCM
20
Deuterium Capital Management
Florida
– -$121K -146,745 Closed
CC
21
Casdin Capital
New York
– -$102K -123,839 Closed
BCM
22
Bridgeway Capital Management
Texas
– -$98.1K -118,927 Closed
Squarepoint
23
Squarepoint
New York
– -$93.7K -113,607 Closed
Northern Trust
24
Northern Trust
Illinois
– -$70.3K -85,222 Closed
SB
25
Samsara BioCapital
California
– -$64.5K -78,131 Closed
1
2

KRON Hedge Fund Activity: Q2 2025 in Review

0 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q2 2025, worth a combined $0 — down 100% from $15.8M a quarter earlier.

Sellers outnumbered buyers: 47 funds closed out of KRON and 0 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Vida Ventures Advisors, exiting entirely with an estimated $2.28M sold.

  • 0 institutional investors held Kronos Bio (KRON) as of Q2 2025, down from 47 in Q1 2025.
  • Funds reported $0 of Kronos Bio stock for Q2 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Kronos Bio positions in Q2 2025 and 47 closed out, a net change of -47 holders.
  • The largest Kronos Bio seller in Q2 2025 was Vida Ventures Advisors, an estimated $2.28M sold.

Based on aggregated 13F filings for Q2 2025.